NTGN
Neon Therapeutics

1,005
Loading...
Loading...
BioNTech US, Inc. develops novel therapeutics leveraging neoantigen biology to treat cancer. It offers NEO-PV-01, a personalized neoantigen vaccine that builds upon initial clinical trials. The company was founded by James P. Allison, Edward J. Fritsch, Nir Hacohen, Eric S. Lander, Robert Schreiber, Ton Schumacher and Catherine Wu on October 21, 2013 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Neon Therapeutics Inc?
What is the 52-week high for Neon Therapeutics Inc?
What is the 52-week low for Neon Therapeutics Inc?
What is Neon Therapeutics Inc stock price today?
What was Neon Therapeutics Inc stock price yesterday?
What is the PE ratio of Neon Therapeutics Inc?
What is the Price-to-Book ratio of Neon Therapeutics Inc?
What is the 50-day moving average of Neon Therapeutics Inc?

Latest NTGN News

View
No NTGN news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.